Zobrazeno 1 - 10
of 300
pro vyhledávání: '"Suppression of tumorigenicity 2"'
Publikováno v:
环境与职业医学, Vol 41, Iss 11, Pp 1221-1226 (2024)
BackgroundSome occupational asthma patients have a high risk of poor prognosis, and early assessment and screening of the high-risk groups with poor prognosis are crucial.ObjectiveTo evaluate the prognostic value of serum histone deacetylase 2 (HDAC2
Externí odkaz:
https://doaj.org/article/6cdd539cf1594b8a9047ca72659a36c7
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Microvascular obstruction (MVO) develops in approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI) after undergoing percutaneous coronary intervention (PCI). MVO is strongly linked to inflammation, m
Externí odkaz:
https://doaj.org/article/c05b34366a294ce09301446e92c2e49b
Publikováno v:
Annals of Intensive Care, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract In cardiogenic shock, biomarkers should ideally help make the diagnosis, choose the right therapeutic options and monitor the patient in addition to clinical and echocardiographic indices. Among “old” biomarkers that have been used for d
Externí odkaz:
https://doaj.org/article/f8701c00bd4b4ade9a7c56465aaf0369
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
ObjectiveSoluble suppression of tumorigenicity 2 (sST2) is associated with the prognosis of some cardiac diseases, but studies on sST2 and the prognosis of patients with myocarditis are rare. This study investigated the relationship between major adv
Externí odkaz:
https://doaj.org/article/99ba25d8afa940ee97c4804f1181cc24
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 2431-2438 (2023)
Zhigan Lv,1,2,* Guohua Liang,3,4,* Mengyu Cheng5,6 1Department of Anesthesiology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Re
Externí odkaz:
https://doaj.org/article/86007347cdeb4eb7b9e9da850d9953c5
Autor:
Julia M. Kröpfl, Fernando G. Beltrami, Hans‐Jürgen Gruber, Arno Schmidt‐Trucksäss, Thomas Dieterle, Christina M. Spengler
Publikováno v:
Experimental Physiology, Vol 108, Iss 10, Pp 1259-1267 (2023)
Abstract Long‐term, intense endurance exercise training can occasionally induce endothelial micro‐damage and cardiac fibrosis. The underlying mechanisms are incompletely understood. Twenty healthy, well‐trained male participants (10 runners and
Externí odkaz:
https://doaj.org/article/6120ad9c4a4c437eafeb20c3a939e719
Publikováno v:
Open Life Sciences, Vol 18, Iss 1, Pp 801-10 (2023)
Externí odkaz:
https://doaj.org/article/4e3c7863cb9f426985805483410a2ba5
Publikováno v:
Vascular Health and Risk Management, Vol Volume 19, Pp 411-420 (2023)
Areej Alkhateeb,1 Hossam Eldin M Mahmoud,1 Mohammed AK,1 Mohammed H Hassan,2 Abdel Rahim Mahmoud Muddathir,3 Ahmed G Bakry1 1Cardiology Division of Internal Medicine Department, South Valley University Hospital, Faculty of Medicine, South Valley Univ
Externí odkaz:
https://doaj.org/article/0006f9d5a8dd413c8df852d186f1ec4c
Publikováno v:
Children, Vol 11, Iss 6, p 718 (2024)
Introduction: The suppression of tumorigenicity 2 (ST2) is a receptor member belonging to the interleukin-1 (IL-1) family. The ligand and soluble versions are its two isoforms. The IL-33-ST2L ligand complex’s development provides protection against
Externí odkaz:
https://doaj.org/article/faf36425ba1e4079bb8710f471aed562
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2024)
PurposeAtrial fibrosis is the main pathological basis for the pathogenesis and progression of atrial fibrillation (AF). Soluble suppression of tumorigenicity 2 (sST2) is involved in fibrosis. Recent studies have explored its predictive value in AF ou
Externí odkaz:
https://doaj.org/article/f464b7a33f894854926bdb4752c1b7dc